000 01459 a2200433 4500
005 20250514190009.0
264 0 _c20040728
008 200407s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.125.5.1888
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFile, Thomas M
245 0 0 _aGuidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
_h[electronic resource]
260 _bChest
_cMay 2004
300 _a1888-901 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCanada
650 0 4 _aCommunity-Acquired Infections
_xdrug therapy
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aEurope
650 0 4 _aFluoroquinolones
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLactams
_xtherapeutic use
650 0 4 _aMacrolides
_xtherapeutic use
650 0 4 _aPneumonia, Bacterial
_xdrug therapy
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aUnited States
700 1 _aGarau, Javier
700 1 _aBlasi, Francesco
700 1 _aChidiac, Christian
700 1 _aKlugman, Keith
700 1 _aLode, Hartmut
700 1 _aLonks, John R
700 1 _aMandell, Lionel
700 1 _aRamirez, Julio
700 1 _aYu, Victor
773 0 _tChest
_gvol. 125
_gno. 5
_gp. 1888-901
856 4 0 _uhttps://doi.org/10.1378/chest.125.5.1888
_zAvailable from publisher's website
999 _c14845914
_d14845914